ConductScience.org, home

Paper8388317

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.

Grøndahl-Hansen J and 6 others. Cancer Res, 1993. Cited by 350 papers, by iCite.

Cite this record

ConductScience Library. High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Papers, record 8388317. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8388317

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.
PubMed
Journal
Cancer Res
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
350
iCite
Relative citation ratio, by iCite
9.58
iCite
Revised in PubMed
2008-11-21
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grøndahl-Hansen JJ
2Christensen IJI J
3Rosenquist CC
4Brünner NN
5Mouridsen HTH T
6Danø KK
7Blichert-Toft MM

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Carcinoma, Intraductal, NoninfiltratingMajor topic
CytosolMajor topic
Plasminogen Activator Inhibitor 1Major topic
Urokinase-Type Plasminogen ActivatorMajor topic
Adult
Aged
Aged, 80 and over
Female
Humans
Menopause
Middle Aged
Multivariate Analysis
Prognosis
Retrospective Studies
Survival Analysis

Source PubMed

Download CSV of topics

Cited by82

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 350 citations.

PMIDTitleJournalYearIn PapersSource
40074769Integrated analysis and experimental validation reveal the prognostic and immunological features associated with coagulation in hepatocellular carcinoma.Sci Rep2025https://conductscience.org/library/papers/40074769PubMed
39754146Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway.Chin Med2025https://conductscience.org/library/papers/39754146PubMed
34621293A Coagulation-Related Gene-Based Prognostic Model for Invasive Ductal Carcinoma.Front Genet2021https://conductscience.org/library/papers/34621293PubMed
33904394Vascular-derived SPARC and SerpinE1 regulate interneuron tangential migration and accelerate functional maturation of human stem cell-derived interneurons.Elife2021https://conductscience.org/library/papers/33904394PubMed
33597950A Phenomic Perspective on Factors Influencing Breast Cancer Treatment: Integrating Aging and Lifestyle in Blood and Tissue Biomarker Profiling.Front Immunol2020https://conductscience.org/library/papers/33597950PubMed
28506312Pathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situ.Breast Cancer Res2017https://conductscience.org/library/papers/28506312PubMed
28302670Modelling pulmonary microthrombosis coupled to metastasis: distinct effects of thrombogenesis on tumorigenesis.Biol Open2017https://conductscience.org/library/papers/28302670PubMed
27432752Development of a Biomimetic Chondroitin Sulfate-modified Hydrogel to Enhance the Metastasis of Tumor Cells.Sci Rep2016https://conductscience.org/library/papers/27432752PubMed
26876202Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer.Oncogene2016https://conductscience.org/library/papers/26876202PubMed
26431317Synergistic Gene Expression Signature Observed in TK6 Cells upon Co-Exposure to UVC-Irradiation and Protein Kinase C-Activating Tumor Promoters.PLoS One2015https://conductscience.org/library/papers/26431317PubMed
26037168Serine Protease Inhibitor Kazal Type 1 (SPINK1) Promotes Proliferation of Colorectal Cancer Through the Epidermal Growth Factor as a Prognostic Marker.Pathol Oncol Res2015https://conductscience.org/library/papers/26037168PubMed
25797271Secreted uPAR isoform 2 (uPAR7b) is a novel direct target of miR-221.Oncotarget2015https://conductscience.org/library/papers/25797271PubMed
25677449uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies.Breast Cancer Res2014https://conductscience.org/library/papers/25677449PubMed
24693431Expression of uPA, tPA, and PAI-1 in Calcified Aortic Valves.Biochem Res Int2014https://conductscience.org/library/papers/24693431PubMed
24494029An ultra-sensitive immunoassay for quantifying biomarkers in breast tumor tissue.J Cancer2014https://conductscience.org/library/papers/24494029PubMed
24222329A novel discriminant score based on tumor-associated trypsin inhibitor for accurate diagnosis of metastasis in patients with breast cancer.Tumour Biol2014https://conductscience.org/library/papers/24222329PubMed
21975339Molecular changes consistent with increased proliferation and invasion are common in rectal cancer.Clin Transl Oncol2011https://conductscience.org/library/papers/21975339PubMed
20931209The plasminogen activator inhibitor system in colon cancer cell lines is influenced by the CO2 pneumoperitoneum.Int J Colorectal Dis2011https://conductscience.org/library/papers/20931209PubMed
20657647MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice.PLoS One2010https://conductscience.org/library/papers/20657647PubMed
20626406Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.Cardiovasc Ther2010https://conductscience.org/library/papers/20626406PubMed

See all 82 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
PLAU5328PubTator's text mininghttps://conductscience.org/library/genes/5328NCBI Gene
PLG5340PubTator's text mininghttps://conductscience.org/library/genes/5340NCBI Gene
SERPINE15054PubTator's text mininghttps://conductscience.org/library/genes/5054NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8388317

GET https://conductscience.org/api/papers/v1/8388317/cited_by?page=2